Gefitinib Teva

Gefitinib Teva is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to therapy.

Gefitinib Teva is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic markers. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow down the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib Teva used for?' and the answer lies in its ability to target cancer cells with EGFR mutations.

Common effects of Gefitinib Teva may include skin rash, diarrhea, and fatigue. Some users may also experience nausea or loss of appetite. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Gefitinib Teva should be handled with care, especially for those with pre-existing medical conditions. It is important to follow the advice of a healthcare professional regarding its use. Pregnant women or those planning to become pregnant should discuss the potential risks with their doctor.

Gefitinib Teva may interact with certain medications, including those that are metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how Gefitinib Teva works.